Co la lev go eR

H s

e e

a vil tth uc ca er xe E

CREDITS

Prof. Nasidi - NCDC

Dr. Sani Gwarzo - FMOH

Dr. Emmanuel Abanida - NPHCDA

Dr. Peter Piot - UNAIDS

Dr. S.A Pattyn

K.M Johnson - CDC Allanta

Mr. Natham Wolfe - Metabiota

J.C Larreche

Kieram Corcoran

Taylor Wofford

Asmau S. Mohammed - NHIS

SENIOR EDITORS

Godwin Odemijie

Moji Makanjuola

INSTITUTIONAL COLUMNISTS

National Health Insurance Scheme

Nigeria Centre for Disease Control

Sure P MCH

INTERNATIONAL AFFAIRS BUREAU CHIEF

Vicky Akai Dare

DIRECTOR - EDITORIAL OFFICE

Nkechi D. Abolo

Marketing Manager

Zubby Onwumere

STAFF GRAPHIC DESIGNER

Kenneth Ameh

SCRIPT EDITORS

Therie Essien

RCHE Faculty Advisors

Prof. Rowland Ndoma-Egba

Prof. Femi Adebanjo

Prof. Okey Mbonu

Dr. Ibrahim Wada

Dr. A Dutse

Barr. Charles Okei

Mr. Fidel Anyanna

Mr. R. Mannason

EDITOR IN CHIEF

Emmanuel C. Abolo

Pharm ccessF O U N D A T I O N

Phillips Pharmaceuticals (Nig) Limited

TRYS OIN FI HM EL A

A LTR

HED

EF

Nigeria Centre for Disease Control

N C D C

Nigeria Centre for Disease Control

Healthcare Management Review

Vol 7/Page 36

YAMBUKU EQUATORIAL

PROVINCE, ZAIRE.

This Case Study reveals the consecutive measures applied in the containment

and surveillance during and after the epidemic in Yambuku area.

Case Study

1976

he combined effects of the technological

Tdriven Mobi le Health Insurance Programme (NMHIP) and the Pupils in Public

Primary School Social Health Insurance

Programme (PPPSHIP) hold the prospects of

covering more than forty percent of

Nigerians, thus setting a new ceiling.